Compare IPSC & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | NREF |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.5M | 296.5M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | NREF |
|---|---|---|
| Price | $1.93 | $16.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $4.25 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 662.1K | 46.9K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 13.95% |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $12.36 |
| 52 Week High | $2.97 | $18.43 |
| Indicator | IPSC | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 50.58 |
| Support Level | $1.90 | $16.33 |
| Resistance Level | $2.62 | $17.22 |
| Average True Range (ATR) | 0.12 | 0.62 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 13.64 | 17.26 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.